1285 related articles for article (PubMed ID: 23174408)
1. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
[TBL] [Abstract][Full Text] [Related]
2. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.
Tran TH; Poudel BK; Marasini N; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Feb; 443(1-2):50-7. PubMed ID: 23318367
[TBL] [Abstract][Full Text] [Related]
4. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release.
Tran PH; Tran HT; Lee BJ
J Control Release; 2008 Jul; 129(1):59-65. PubMed ID: 18501462
[TBL] [Abstract][Full Text] [Related]
5. Solubilization of the poorly water soluble drug, telmisartan, using supercritical anti-solvent (SAS) process.
Park J; Cho W; Cha KH; Ahn J; Han K; Hwang SJ
Int J Pharm; 2013 Jan; 441(1-2):50-5. PubMed ID: 23262425
[TBL] [Abstract][Full Text] [Related]
6. Novel oral formulation approach for poorly water-soluble drug using lipocalin-type prostaglandin D synthase.
Mizoguchi M; Nakatsuji M; Inoue H; Yamaguchi K; Sakamoto A; Wada K; Inui T
Eur J Pharm Sci; 2015 Jul; 74():77-85. PubMed ID: 25906910
[TBL] [Abstract][Full Text] [Related]
7. Development of raloxifene-solid dispersion with improved oral bioavailability via spray-drying technique.
Tran TH; Poudel BK; Marasini N; Woo JS; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2013 Jan; 36(1):86-93. PubMed ID: 23325488
[TBL] [Abstract][Full Text] [Related]
8. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
10. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
11. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
12. Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies.
McFall H; Sarabu S; Shankar V; Bandari S; Murthy SN; Kolter K; Langley N; Kim DW; Repka MA
Int J Pharm; 2019 Jan; 554():302-311. PubMed ID: 30395959
[TBL] [Abstract][Full Text] [Related]
13. Enhanced solubility and bioavailability of flurbiprofen by cycloamylose.
Baek HH; Kwon SY; Rho SJ; Lee WS; Yang HJ; Hah JM; Choi HG; Kim YR; Yong CS
Arch Pharm Res; 2011 Mar; 34(3):391-7. PubMed ID: 21547670
[TBL] [Abstract][Full Text] [Related]
14. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.
Sangwai M; Vavia P
Int J Pharm; 2013 Sep; 453(2):423-32. PubMed ID: 22935741
[TBL] [Abstract][Full Text] [Related]
15. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
Yang M; He S; Fan Y; Wang Y; Ge Z; Shan L; Gong W; Huang X; Tong Y; Gao C
Int J Pharm; 2014 Nov; 475(1-2):97-109. PubMed ID: 25171976
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
[TBL] [Abstract][Full Text] [Related]
17. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
Chella N; Tadikonda R
Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
[TBL] [Abstract][Full Text] [Related]
18. A novel surface-attached carvedilol solid dispersion with enhanced solubility and dissolution.
Lee SN; Poudel BK; Tran TH; Marasini N; Pradhan R; Lee YI; Lee DW; Woo JS; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2013 Jan; 36(1):79-85. PubMed ID: 23328872
[TBL] [Abstract][Full Text] [Related]
19. Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability.
Pradhan R; Tran TH; Choi JY; Choi IS; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2015 Apr; 38(4):522-33. PubMed ID: 24895145
[TBL] [Abstract][Full Text] [Related]
20. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
